The Amicus Separator’s single-use disposable kit combined with the Phelix Photoactivation Device create an online, closed system to perform photopheresis. The patient remains connected to the Amicus device throughout the procedure. After photoactivation, Amicus reinfuses the treated cells back to the patient.
Amicus Blue ECP System
The Phelix Photoactivation Device is used to provide extracorporeal photoimmunotherapy when used in conjunction with the Amicus Separator Device.
The Phelix Device promotes safety and performance utilizing multiple sensors to ensure consistent temperature, mixing and UV-A light exposure.
VIDEO: Amicus Blue in Children and Adolescents with GVHD
Dr. Volker Witt from St. Anna Kinderspital in Vienna, Austria reports on their year-long study of using the Amicus Blue ECP system for the treatment of GVHD in children.
The Amicus ECP System can be configured to perform ECP procedures if cleared by the appropriate local regulatory agencies. Amicus ECP has CE Mark approval in accordance with the Medical Device Directive for the indication of CTCL for distribution in Europe. It is not CE marked for the treatment of cGVHD. Amicus ECP is not cleared for market in the United States.
The Amicus ECP System is CE marked for distribution in Europe. It is not cleared for market in the United States.
Contact your local Fresenius Kabi representative to learn more about Amicus Blue.
Refer to the Amicus Separator operator's manual for the full list of warnings and cautions associated with the use of the devices.
